These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2875421)

  • 1. Early and late effects of systemically administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase activity in vitro and on tyrosine hydroxylation in tissue slices of mouse striatum.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1986 Jul; 68(2):245-8. PubMed ID: 2875421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Hirata Y; Nagatsu T
    Brain Res; 1985 Jun; 337(1):193-6. PubMed ID: 2860954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu I; Nagatsu T
    Neurosci Lett; 1987 Sep; 80(2):213-8. PubMed ID: 2891089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
    Matsuda LA; Schmidt CJ; Hanson GR; Gibb JW
    Neuropharmacology; 1986 Mar; 25(3):249-55. PubMed ID: 2871513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA; Walters AS; Heikkila RE
    Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.
    Ambrosio S; Gerli P; Perego C; Algeri S
    Eur J Pharmacol; 1987 Jan; 133(2):239-41. PubMed ID: 2880741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
    Nagatsu T; Hirata Y
    Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice.
    Fornai F; Alessandrì MG; Fascetti F; Vaglini F; Corsini GU
    J Neurochem; 1995 Aug; 65(2):704-9. PubMed ID: 7616226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice.
    Nishi K; Kondo T; Narabayashi H
    Brain Res; 1989 Jun; 489(1):157-62. PubMed ID: 2568151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.
    Wallace RA; Boldry R; Schmittgen T; Miller D; Uretsky N
    Life Sci; 1984 Jul; 35(3):285-91. PubMed ID: 6146909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal ectopic expression of tyrosine hydroxylase in the mouse striatum by combined administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 3-nitropropionic acid.
    Nakahara T; Yamamoto T; Endo K; Kayama H
    Neuroscience; 2001; 108(4):601-10. PubMed ID: 11738497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
    Hirata Y; Sugimura H; Takei H; Nagatsu T
    Brain Res; 1986 Nov; 397(2):341-4. PubMed ID: 3099974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of tetrahydrobiopterin restored the decline of dopamine in the striatum induced by an acute action of MPTP.
    Kurosaki H; Yamaguchi K; Man-Yoshi K; Muramatsu SI; Hara S; Ichinose H
    Neurochem Int; 2019 May; 125():16-24. PubMed ID: 30739038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lu E; Sarkar S; Raymick J; Paule MG; Gu Q
    Brain Res; 2018 Jan; 1678():432-439. PubMed ID: 29158176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.